Gene polymorphisms of angiotensin-converting enzyme and angiotensin II Type I receptor among chronic kidney disease patients in a Chinese population

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 13, Issue 1, 2012, Pages 148-154

  Su, Sui Lung ^a   Lu, Kuo Cheng ^b   Lin, Yuh Feng ^c,d   Hsu, Yu Juei ^d   Lee, Pong Ying ^a   Yang, Hsin Yi ^a   Kao, Sen Yeong ^a  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

angiotensin II type 1 receptor (AGTR1); angiotensin I converting enzyme (ACE); angiotensinogen (AGT); Chronic kidney disease (CKD); single nucleotide polymorphism (SNP)

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CHINESE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC LINKAGE; GENETIC RISK; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; RENAL PROTECTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

ANGIOTENSINOGEN; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; KIDNEY FAILURE, CHRONIC; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR, ANGIOTENSIN, TYPE 1; RENIN-ANGIOTENSIN SYSTEM;

EID: 84859939183     PISSN: 14703203     EISSN: 17528976     Source Type: Journal    
DOI: 10.1177/1470320311430989     Document Type: Article

References (35)

1. US Renal Data System. Annual Data Report. www.usrds.org /2010/pdf/v2-12.pdf
2. National Health Insurance Annual Statistical Report 2003. Department of Health. Taiwan: Executive Yuan, R.O.C. 2003. www.nhicb.gov.tw/Resource /webdata/Attach-8661-1-s92.pdf
3. Wen CP, Cheng TY, Tsai MK, Chang YC, Chan HT, Tsai SP, et al. All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462293 adults in Taiwan. Lancet 2008; 371: 2173-2182. (Pubitemid 351890412)
4. Satko SG, Sedor JR, Iyengar SK and Freedman BI. Familial clustering of chronic kidney disease Semin Dial 2007; 20: 229-236.
5. Hwang SJ, Tsai JC and Chen HC. Epidemiology, impact and preventive care of chronic kidney disease in Taiwan. Nephrology 2010; 15: 3-9.
6. McClellan WM and Flanders WD. Risk factors for progressive chronic kidney disease. J Am Soc Nephrol 2003; 14: S65-S70. (Pubitemid 36750495)
7. Luttropp K, Lindholm B, Carrero JJ, Glorieux G, Schepers E, Vanholderet R, et al. Genetics/genomics in chronic kidney disease - towards personalized medicine? Semin Dial 2009; 22: 417-422.
8. Crisan D and Carr J. Angiotensin I-converting enzyme: genotype and disease associations. J Mol Diagn 2000; 2: 105-115.
9. Ortiz MA, De Prado A, Doñate T, Gallart L, Claramunt H, Hernandez M, et al. Angiotensin converting enzyme polymorphism gene and evolution of nephropathy to end stage renal disease. Nephrology 2003; 8: 171-176. (Pubitemid 36995086)
10. Miller JA and Scholey JW. The impact of renin-angiotensin system polymorphisms on physiological and pathophysiological processes in humans. Curr Opin Nephrol Hypertens 2004; 13: 101-106. (Pubitemid 39069905)
11. Schmidt S, Schöne N and Ritz E. Association of ACE gene polymorphism and diabetic nephropathy? The Diabetic Nephropathy Study Group. Kidney Int 1995; 47: 1176-1181.
12. Dudley CR, Keavney B, Stratton IM, Turner RC and Ratcliffe PJ. U.K. Prospective Diabetes Study. XV: Relationship of renin-angiotensin system gene polymorphisms with microalbuminuria in NIDDM. Kidney Int 1995; 48: 1907-1911.
13. Lovati E, Richard A, Frey BM, Frey FJ and Ferrari P. Genetic polymorphisms of the renin-angiotensin-aldosterone system in end-stage renal disease. Kidney Int 2001; 60: 46-54. (Pubitemid 32587538)
14. Viswanathan V, Zhu Y, Bala K, Dunn S, Snehalatha C, Ramachandran A, et al. Association between ACE gene polymorphism and diabetic nephropathy in South Indian patients. JOP 2001; 2: 83-87. (Pubitemid 38963875)
15. Prasad P, Tiwari AK, Kumar K, Prasanna Kumar KM, Ammini AC, Gupta A, et al. Chronic renal insufficiency among Asian Indians with type 2 diabetes: I. Role of RAAS gene polymorphisms. BMC Med Genet 2006; 7: 42.
16. Levey A, Greene T, Kusek J and Beck G. A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol 2000; 11: 155A.
17. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003; 139: 137-147.
18. Poncz M, Solowiejczyk D, Harpel B, Mory Y, Schwartz E, Surrey S, et al. Construction of human gene libraries from small amounts of peripheral blood. Hemoglobin 1982; 6: 27-36.
19. Caulfield M, Lavender P, Farrall M, Munroe P, Lawson M, Turner PC, et al. Linkage of the angiotensinogen gene to essential hypertension. N Engl J Med 1994; 330: 1629-1633. (Pubitemid 24166862)
20. Baudin B. Polymorphism in angiotensin II receptor genes and hypertension. Exp Physiol 2005; 90: 277-282. (Pubitemid 40685839)
21. Gumprecht J, Zychma MJ, Grzeszczak W and Zukowska-Szczechowska E. Angiotensin I-converting enzyme gene insertion/deletion and angiotensinogen M235T polymorphisms: risk of chronic renal failure. Kidney Int 2000; 58: 513-519. (Pubitemid 30620000)
22. Rogus JJ, Moczulski D, Freire MB, Yang Y, Warram JH, Krolewski AS, et al. Diabetic nephropathy is associated with AGT polymorphism T235: results of a family-based study. Hypertension 1998; 31: 627-631.
23. Vasků A, Soucek M, Tschöplová S and Stejskalová A. An association of BMI with A (-6) G, M235T and T174M polymorphisms in angiotensinogen gene in essential hypertension. J Hum Hypertens 2002; 16: 427-430.
24. Zhu X, Bouzekri N, Southam L, Cooper RS, Adeyemo A, McKenzie CA, et al. Linkage and association analysis of angiotensin I-converting enzyme (ACE)-gene polymorphisms with ACE concentration and blood pressure. Am J Hum Genet 2001; 68: 1139-1148.
25. Frimat L, Philippe C, Maghakian MN, Jonveaux P, Hurault de Ligny B, Guillemin F, et al. Polymorphism of angiotensin converting enzyme, angiotensinogen, and angiotensin II type 1 receptor genes and end-stage renal failure in IgA nephropathy: IGARAS - Xa study of 274 men. J Am Soc Nephrol 2000; 11: 2062-2067.
26. Tomino Y, Makita Y, Shike T, Gohda T, Haneda M, Kikkawa R, et al. Relationship between polymorphism in the angiotensinogen, angiotensin-converting enzyme or angiotensin II receptor and renal progression in Japanese NIDDM patients. Nephron 2000; 82: 139-144. (Pubitemid 29263973)
27. Jeunemaitre X, Soubrier F, Kotelevtsev YV, Lifton RP, Williams CS, Charru A, et al. Molecular basis of human hypertension: role of angiotensinogen. Cell 1992; 71: 169-180.
28. Chang SN, Lin JW, Juang JM, Tsai CT, Hwang JJ and Chiang FT. Association between genetic polymorphisms in the renin-angiotensin system and systolic heart failure revised by a propensity score-based analysis. Cardiology 2010; 116: 279-285.
29. Doria A, Warram J, Rich S and Krolewski A. Angiotensin I-converting enzyme (ACE): estimation of DNA haplotypes in unrelated individuals using denaturing gradient gel blots. Hum Gene 1994; 94: 117-123. (Pubitemid 24232041)
30. Niu W, Qi Y, Hou S, Zhai X, Zhou W and Qiu C. Haplotype-based association of the renin-angiotensin-aldosterone system genes polymorphisms with essential hypertension among Han Chinese: the Fangshan study. J Hypertens 2009; 27: 1384-1391.
31. Pan M, Zhu JH, Liu ZH, Jiang WP, Cui ZC, Yu XH, et al. Angiotensin-converting enzyme gene 2350 G/A polymorphism is associated with left ventricular hypertrophy but not essential hypertension. Hypertens Res 2007; 30: 31-37.
32. Curnow KM, Pascoe L and White P. Genetic analysis of the human type-1 angiotensin II receptor. Mol Endocrinol 1992; 6: 1113-1118.
33. Buraczynska M, Ksiazek P, Drop A, Zaluska W, Spasiewicz D and Ksiazek A. Genetic polymorphisms of the renin-angiotensin system in end-stage renal disease. Nephrol Dial Transplant 2006; 21: 979-983.
34. Buraczynska M, Ksiazek P, Zaluska W, Spasiewicz D, Nowicka T and Ksiazek A. Angiotensin II type 1 receptor gene polymorphism in end-stage renal disease. Nephron 2000; 92: 51-55.
35. Tarnow L, Cambien F, Rossing P, Nielsen FS, Hansen BV, Ricard S, et al. Angiotensin-II type 1 receptor gene polymorphism and diabetic microangiopathy. Nephrol Dial Transplant 1996; 11: 1019-1023. (Pubitemid 26182492)